William Desmarais
Plus aucun poste en cours
Profil
William Desmarais served as Vice President-Business Development at Momenta Pharmaceuticals, Inc. from 2017 to 2021.
He then worked as Chief Business Officer at TScan Therapeutics, Inc. from 2021 to 2023.
Desmarais holds an MBA from Massachusetts Institute of Technology, a doctorate from Brandeis University, and an undergraduate degree from Purdue University.
Anciens postes connus de William Desmarais
| Sociétés | Poste | Fin |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2023 |
| MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/02/2021 |
Formation de William Desmarais
| Brandeis University | Doctorate Degree |
| Massachusetts Institute of Technology | Masters Business Admin |
| Purdue University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TSCAN THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |